Simplex Trading
FBIO icon

Simplex Trading’s Fortress Biotech FBIO Stock Holding History

Simplex Trading’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.9K Sell
1,600
-17,800
-92% -$45.9K ﹤0.01% 8190
2026
Q1 		$54.1K Sell
19,400
-85,400
-81% -$290K ﹤0.01% 5799
2025
Q4 		$384K Buy
104,800
+38,200
+57% +$109K ﹤0.01% 3564
2025
Q3 		$246K Buy
66,600
+65,900
+9,414% +$167K ﹤0.01% 4693
2025
Q2 		$1K Sell
700
-38,100
-98% -$66K ﹤0.01% 8308
2025
Q1 		$60K Sell
38,800
-8,100
-17% -$14.3K ﹤0.01% 5589
2024
Q4 		$94K Buy
46,900
+9,400
+25% +$17K ﹤0.01% 5226
2024
Q3 		$54K Buy
+37,500
New +$71.4K ﹤0.01% 5810
2024
Q2 		– Sell
-4,700
Closed -$9K – 9057
2024
Q1 		$9K Buy
4,700
+3,300
+236% +$6.57K ﹤0.01% 7670
2023
Q4 		$4K Buy
+1,400
New +$3.7K ﹤0.01% 7959
2023
Q2 		– Sell
-120
Closed -$1K – 9237
2023
Q1 		$1K Sell
120
-6,000
-98% -$71.4K ﹤0.01% 8684
2022
Q4 		$60K Sell
6,120
-667
-10% -$7.38K ﹤0.01% 5642
2022
Q3 		$87K Buy
6,787
+6,060
+834% +$90.8K ﹤0.01% 5711
2022
Q2 		$9K Buy
727
+534
+277% +$7.91K ﹤0.01% 8359
2022
Q1 		$3K Sell
193
-7,934
-98% -$217K ﹤0.01% 9683
2021
Q4 		$304K Buy
8,127
+2,587
+47% +$115K ﹤0.01% 4543
2021
Q3 		$307K Buy
5,540
+40
+0.7% +$1.95K ﹤0.01% 4873
2021
Q2 		$294K Buy
+5,500
New +$332K ﹤0.01% 5015
2017
Q3 		– Sell
-7
Closed -$5K – 6083
2017
Q2 		$5K Buy
7
+5
+250% +$295 ﹤0.01% 4573
2017
Q1 		$3K Buy
+2
New +$89 ﹤0.01% 4970
2015
Q3 		– Sell
-5
Closed -$6K – 5686
2015
Q2 		$6K Buy
5
+1
+25% +$51 ﹤0.01% 3502
2015
Q1 		$1K Buy
+4
New +$167 ﹤0.01% 4456

Other funds holding FBIO

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Simplex Trading's FBIO Position: Q2 2026 in Review

Simplex Trading reduced its Fortress Biotech (FBIO) stake by 75% in Q2 2026, selling an estimated $113K and leaving 14,508 shares worth $44.4K. The position accounts for ﹤0.01% of the portfolio, ranked #6414.

Simplex Trading first reported a position in FBIO in Q4 2015 and has held it in 20 quarters since. The position peaked at $201K in Q3 2025. 55 funds tracked by Wall St. Rank hold FBIO as of Q2 2026.

  • Simplex Trading held 14,508 shares of Fortress Biotech worth $44.4K as of Q2 2026.
  • Simplex Trading sold 43,821 Fortress Biotech shares in Q2 2026, an estimated $113K.
  • Fortress Biotech made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #6414 holding.
  • Simplex Trading first reported a position in Fortress Biotech in Q4 2015 and has held it in 20 quarters since.
  • Simplex Trading's Fortress Biotech position peaked at $201K in Q3 2025.
  • 55 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.